Lanzafame H (2026). [PMID: 41714122](https://pubmed.ncbi.nlm.nih.gov/41714122/). *J Nucl Med*. [Epidemiology / Natural History]
Lee D (2026). [PMID: 41512080](https://pubmed.ncbi.nlm.nih.gov/41512080/). *Sci Immunol*. [Review / Meta-Analysis]
Hasenböhler A (2026). [PMID: 41500678](https://pubmed.ncbi.nlm.nih.gov/41500678/). *BMJ*. [Epidemiology / Natural History]
Howard TP (2026). [PMID: 41529791](https://pubmed.ncbi.nlm.nih.gov/41529791/). *Int J Radiat Oncol Biol Phys*. [Clinical Trial Publication]
Harry J (2025). [PMID: 39919489](https://pubmed.ncbi.nlm.nih.gov/39919489/). *Cancer Epidemiol*. [Review / Meta-Analysis]
Lee SY (2025). [PMID: 40530565](https://pubmed.ncbi.nlm.nih.gov/40530565/). *Sci Prog*. [Epidemiology / Natural History]
Tsukahara S (2025). [PMID: 40716035](https://pubmed.ncbi.nlm.nih.gov/40716035/). *Cancer Med*. [Basic Science / Preclinical]
Qu B (2025). [PMID: 40566486](https://pubmed.ncbi.nlm.nih.gov/40566486/). *Life (Basel)*. [Epidemiology / Natural History]
Byrne L (2025). [PMID: 40533153](https://pubmed.ncbi.nlm.nih.gov/40533153/). *J Med Genet*. [Clinical Trial Publication]
Perletti G (2025). [PMID: 40503579](https://pubmed.ncbi.nlm.nih.gov/40503579/). *Arch Ital Urol Androl*. [Review / Meta-Analysis]
